BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 22470775)

  • 1. Orbital plasmablastic lymphoma with remission following chemotherapy.
    Degnan AJ; Levy LM
    J Radiol Case Rep; 2011; 5(2):1-7. PubMed ID: 22470775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Orbital plasmablastic lymphoma--comparison of a newly reported entity with diffuse large B-cell lymphoma of the orbit.
    Morley AM; Verity DH; Meligonis G; Rose GE
    Orbit; 2009; 28(6):425-9. PubMed ID: 19929677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Front-line immunochemotherapy for aggressive non-Hodgkin lymphoma using dose-dense rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone plus granulocyte-macrophage colony stimulating factor and pegfilgrastim as support.
    Cabanillas F; Cotto M; Liboy I; Rivera E; Pavia OA; Bruno M
    Leuk Lymphoma; 2012 Oct; 53(10):1929-33. PubMed ID: 22448918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous plasmablastic lymphoma.
    Jambusaria A; Shafer D; Wu H; Al-Saleem T; Perlis C
    J Am Acad Dermatol; 2008 Apr; 58(4):676-8. PubMed ID: 18342714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bortezomib in combination with infusional dose-adjusted EPOCH for the treatment of plasmablastic lymphoma.
    Castillo JJ; Reagan JL; Sikov WM; Winer ES
    Br J Haematol; 2015 May; 169(3):352-5. PubMed ID: 25612847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Orbital manifestations of B-cell acute lymphoblastic leukemia/lymphoma.
    Strawbridge JC; Roelofs KA; Naderi J; Goh TY; Rootman DB
    Orbit; 2023 Dec; 42(6):654-658. PubMed ID: 35580237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Orbital involvement in extranodal natural killer T cell lymphoma: an atypical case presentation and review of the literature.
    Ely A; Evans J; Sundstrom JM; Malysz J; Specht CS; Wilkinson M
    Orbit; 2012 Aug; 31(4):267-9. PubMed ID: 22681504
    [TBL] [Abstract][Full Text] [Related]  

  • 8. An aggressive primary orbital natural killer/T-cell lymphoma case: poor response to chemotherapy.
    Marchino T; Ibáñez N; Prieto S; Novelli S; Szafranska J; Mozos A; Graell X; Buil JA
    Ophthalmic Plast Reconstr Surg; 2014; 30(5):e131-4. PubMed ID: 24317101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Lymphoproliferative lesions of the ocular adnexa. Differential diagnostic guidelines].
    Coupland SE
    Ophthalmologe; 2004 Feb; 101(2):197-215; quiz 216-7. PubMed ID: 15046030
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of two different schedules of granulocyte-colony-stimulating factor during treatment for acute lymphocytic leukemia with a hyper-CVAD (cyclophosphamide, doxorubicin, vincristine, and dexamethasone) regimen.
    Weiser MA; O'Brien S; Thomas DA; Pierce SA; Lam TP; Kantarjian HM
    Cancer; 2002 Jan; 94(2):285-91. PubMed ID: 11900213
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasmablastic lymphoma - single centre experience with infusional EPOCH chemotherapy.
    Jayachandran PK; Rajan AK; Karunakaran P; Mehra N; Selvarajan G; Kesana S; Dhanushkodi M; Radhakrishnan V; Sagar TG
    Leuk Res; 2020 Aug; 95():106391. PubMed ID: 32559556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Blurred Vision and Wrinkled Retinas in an Elderly Man.
    Zhao PY; Kahana A; Kim TN
    JAMA Ophthalmol; 2019 Feb; 137(2):226-227. PubMed ID: 30589928
    [No Abstract]   [Full Text] [Related]  

  • 13. Primary Maxillary Sinus Plasmablastic Lymphoma in HIV/AIDS.
    Basavaraj A; Kadam M; Kadam DB
    J Assoc Physicians India; 2016 May; 64(5):71-72. PubMed ID: 27735156
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of staging and early response to chemotherapy with whole-body diffusion-weighted MRI in malignant lymphoma patients: A comparison with FDG-PET/CT.
    Tsuji K; Kishi S; Tsuchida T; Yamauchi T; Ikegaya S; Urasaki Y; Fujiwara Y; Ueda T; Okazawa H; Kimura H
    J Magn Reson Imaging; 2015 Jun; 41(6):1601-7. PubMed ID: 25111444
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Société Française d'Oncologie Pédiatrique LMB89 protocol: highly effective multiagent chemotherapy tailored to the tumor burden and initial response in 561 unselected children with B-cell lymphomas and L3 leukemia.
    Patte C; Auperin A; Michon J; Behrendt H; Leverger G; Frappaz D; Lutz P; Coze C; Perel Y; Raphaël M; Terrier-Lacombe MJ;
    Blood; 2001 Jun; 97(11):3370-9. PubMed ID: 11369626
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Subcutaneous Dissemination from an Orbital Diffuse Large B Cell Lymphoma.
    Bains S; Vidhya N; Kim U; Shanti R; Devanand J
    Orbit; 2015; 34(6):338-9. PubMed ID: 26452055
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cure in a case of primary hepatic lymphoma.
    Murthy SA; Singh B; Bhalla S; Arora A; Vohra R; Aggarwal S
    Indian J Cancer; 2000 Dec; 37(4):165-72. PubMed ID: 12018569
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Squamous cell carcinoma of the conjunctiva invading the orbit in a non-Hodgkin lymphoma.
    Kwon SI; Chung YS; Kim YJ
    Jpn J Ophthalmol; 2009 Nov; 53(6):650-651. PubMed ID: 20020247
    [No Abstract]   [Full Text] [Related]  

  • 19. Unusual presentation of gastric plasmablastic lymphoma in HIV-negative patient.
    Mihaljevic BS; Todorovic MR; Andjelic BM; Antic DA; Perunicic Jovanovic MD
    Med Oncol; 2012 Jun; 29(2):1186-9. PubMed ID: 21476144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fluorodeoxyglucose positron emission tomography in primary thyroid lymphoma with coexisting lymphocytic thyroiditis.
    Arabi M; Dvorak R; Smith LB; Kujawski L; Gross MD
    Thyroid; 2011 Oct; 21(10):1153-6. PubMed ID: 21875367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.